Feb 23 (Reuters) - Kazia Therapeutics Ltd KZA.AX :
* KAZIA RECEIVES FDA ORPHAN DESIGNATION FOR GDC-0084
* KAZIA THERAPEUTICS LTD - PHASE II CLINICAL STUDY OF GDC-0084 IS ANTICIPATED TO PROVIDE AN INITIAL DATA READ-OUT IN EARLY CALENDAR 2019
Feb 23 (Reuters) - Kazia Therapeutics Ltd KZA.AX :
* KAZIA RECEIVES FDA ORPHAN DESIGNATION FOR GDC-0084
* KAZIA THERAPEUTICS LTD - PHASE II CLINICAL STUDY OF GDC-0084 IS ANTICIPATED TO PROVIDE AN INITIAL DATA READ-OUT IN EARLY CALENDAR 2019